Shares of Opexa Therapeutics (OPXA +18%) spike higher today amid heavier-than-usual trading...

|About: Opexa Therapeutics, Inc. (OPXA)|By:, SA News Editor

Shares of Opexa Therapeutics (OPXA +18%) spike higher today amid heavier-than-usual trading volumes. News is light, but the company's 10-K is due out tomorrow, and it could be the catalyst behind the move as investors are anticipating a number of developments in its pipeline. Additionally, an article in Seeking Alpha this morning says the stock is poised to break out for several reasons, citing the strength of its new partnership agreement with Merck Serono, new developments with its lead product candidate, Tcelna, and signs of a large, active institutional buyer in the market.